doi: 10.1097/01.NPR.0000512251.61454.5c.
Bladder cancer: Risk factors, diagnosis, and management
Affiliations
- PMID: 28169964
- DOI: 10.1097/01.NPR.0000512251.61454.5c
Item in Clipboard
Bladder cancer: Risk factors, diagnosis, and management
Nurse Pract.
.
Abstract
Bladder cancer is the most common genitourinary cancer in the United States. Symptoms of bladder cancer mimic those of a urinary tract infection, which can delay timely diagnosis. Because of the high rate of bladder cancer, it is likely advanced practice registered nurses will be responsible for the care of patients with bladder cancer. This article reviews the signs and symptoms of bladder cancer along with management options to safely care for this patient population.
Similar articles
-
Bladder cancer: overview and disease management. Part 1: non-muscle-invasive bladder cancer.Br J Nurs. 2018 May 10;27(9):S27-S37. doi: 10.12968/bjon.2018.27.9.S27. Br J Nurs. 2018. PMID: 29749774
-
Nursing care and treatment of patients with bladder cancer.Nurs Stand. 2009 May 20-26;23(37):47-56; quiz 58. doi: 10.7748/ns2009.05.23.37.47.c6973. Nurs Stand. 2009. PMID: 19517712
-
Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.Int J Urol. 2016 Jan;23(1):42-7. doi: 10.1111/iju.12959. Epub 2015 Oct 6. Int J Urol. 2016. PMID: 26443388
-
Education of the advanced practice nurse in oncology.Oncol Nurs Forum. 1995 Sep;22(8 Suppl):19-24. Oncol Nurs Forum. 1995. PMID: 8524674 Review.
-
Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder.Curr Urol Rep. 2018 Sep 13;19(11):94. doi: 10.1007/s11934-018-0839-3. Curr Urol Rep. 2018. PMID: 30215140 Review.
Cited by
-
STAT3 and Its Pathways' Dysregulation-Underestimated Role in Urological Tumors.Cells. 2022 Sep 27;11(19):3024. doi: 10.3390/cells11193024. Cells. 2022. PMID: 36230984 Free PMC article. Review.
-
Identification of a pyroptosis related gene signature for predicting prognosis and estimating tumor immune microenvironment in bladder cancer.Transl Cancer Res. 2022 Jul;11(7):1865-1879. doi: 10.21037/tcr-22-177. Transl Cancer Res. 2022. PMID: 35966309 Free PMC article.
-
Construction and Validation of a 15-Top-prognostic-gene-based Signature to Indicate the Dichotomized Clinical Outcome and Response to Targeted Therapy for Bladder Cancer Patients.Front Cell Dev Biol. 2022 Mar 31;10:725024. doi: 10.3389/fcell.2022.725024. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35433683 Free PMC article.
-
Bladder cancer: therapeutic challenges and role of 3D cell culture systems in the screening of novel cancer therapeutics.Cancer Cell Int. 2023 Oct 25;23(1):251. doi: 10.1186/s12935-023-03069-4. Cancer Cell Int. 2023. PMID: 37880676 Free PMC article. Review.
-
Ferroptosis and circular RNAs: new horizons in cancer therapy.EXCLI J. 2024 Apr 25;23:570-599. doi: 10.17179/excli2024-7005. eCollection 2024. EXCLI J. 2024. PMID: 38887390 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
